Medical
Stay up-to-date on the latest medical cannabis research, news, and information with Business of Cannabis. Learn about new treatments, laws, and more.
Medical · page 10
- Clinical Research
Can the Company That Built Australia’s Pastilles Market Do It Again in the UK?
Australia’s booming medical cannabis market, now the largest outside of North America, has seen a dramatic shift in consumer preference over the last two years.
- Investment & Finance
French Excellence at the Heart of a High-Capacity EU-GMP Site
PGP Farmer closes a €3m funding round to become a leading player in EU-GMP medical cannabis production in Europe French biotech company PGP Farmer unveils the closing of a €3 million funding round with private investors.
- Prescribers & Clinics
Collapsed Cannim Sees Liquidators Target $32m in Voidable Transactions as UK Creditors Face Enforcement Gap
Collapsed international cannabis operator Cannim has officially been placed into liquidation following a failed sales process, seeing its myriad of creditors vie for their share of the tens of millions of dollars now reportedly outstanding.
- Medical Cannabis
Medical Cannabis Police Guidance Published, But No Training Programme Planned
Medical cannabis once again found itself at the centre of the UK mainstream media’s attention this week, following a troubling coroner’s finding that a prescription ‘contributed to’ a patient’s death.
- Cultivation
Future-Ready: Why Pure Is Building the Cannabis Company Traditional Industry Will Want to Buy Into
Last year, as other European cannabis markets looked to be retreating from their ambitious progress in 2024, Switzerland accelerated its plans for cannabis reform.
- International Regulation
Germany’s Cannabis Future: Political Posturing vs. Market Reality
Last month (January 15, 2026) Germany’s Bundesrag held a debate on the hotly contested amendments aimed at significantly restricting medical cannabis prescriptions, and potentially transforming the industry.
- Clinical Research
Latest Studies Map Cannabis Efficacy Across Pain, Migraine, and Autism Applications
Welcome to Business of Cannabis’ new research digest, unpacking the latest clinical evidence shaping cannabis therapeutics.
- International Regulation
France’s Budget Chaos Nears Resolution, Removing Major Barrier for Medical Cannabis Rollout
Earlier this week (Tuesday, January 27), France’s government survived two no-confidence votes, finally passing its contentious 2026 budget following months of political crisis that had largely paralysed non-urgent policymaking.
- Medical Cannabis
Is Europe Moving Away From Cannabis Flower? – Why Companies Are Betting on CE-Certified Devices
Last week, we reported on an emerging trend in the European medical cannabis industry, which is seeing regulators in incoming markets favour alternative modes of administration, challenging the ubiquity of dried flower.
- Medical Cannabis
UK’s First Medical Cannabis Legal Helpline Launches as Patients Navigate New Police Guidance
UK medical cannabis clinic Releaf has launched a new 24/7 on-demand legal support service for its prescribed patients, helping navigate common issues with their medication with professional guidance.
- International Regulation
Is Europe Moving Away From Cannabis Flower?
Spain’s medicines agency has published the first official guidance for medical cannabis preparations, confirming that its incoming market will exclude raw cannabis flower in favour of ‘standardised’ oral solutions prepared exclusively in hospital pharmacies.
- Patient Access
Seven Years for Progress, Four Days to Undermine It: The UK’s Cannabis Media Storm
On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers in England and Wales, news that UK patients have been waiting since 2018 to receive.
